238 related articles for article (PubMed ID: 23933332)
21. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.
Brotherton JM; Mullins RM
Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834
[TBL] [Abstract][Full Text] [Related]
22. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
[TBL] [Abstract][Full Text] [Related]
23. Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era.
Malagón T; Drolet M; Boily MC; Laprise JF; Brisson M
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):276-85. PubMed ID: 25380735
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
Gauthier A; Martín-Escudero V; Moore L; Ferko N; de Sanjosé S; Pérez-Escolano I; Catalá-López F; Ferrer E; Bosch FX
Eur J Public Health; 2008 Dec; 18(6):674-80. PubMed ID: 18641420
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake.
Donadiki EM; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; López de Andrés A; Velonakis EG
Vaccine; 2012 Nov; 30(49):6967-70. PubMed ID: 23022147
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
[TBL] [Abstract][Full Text] [Related]
27. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer in the human papillomavirus vaccination era.
Tay SK
Curr Opin Obstet Gynecol; 2012 Feb; 24(1):3-7. PubMed ID: 22123221
[TBL] [Abstract][Full Text] [Related]
29. Uptake of the human papillomavirus vaccine: a review of the literature and report of a quality assurance project.
Cassidy B; Schlenk EA
J Pediatr Health Care; 2012 Mar; 26(2):92-101. PubMed ID: 22360928
[TBL] [Abstract][Full Text] [Related]
30. The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination.
Matthijsse SM; Hontelez JAC; Naber SK; van Rosmalen J; Rozemeijer K; Penning C; Bakker R; van Ballegooijen M; de Kok IMCM; de Vlas SJ
Vaccine; 2015 Oct; 33(41):5357-5364. PubMed ID: 26348405
[TBL] [Abstract][Full Text] [Related]
31. Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany.
Blödt S; Holmberg C; Müller-Nordhorn J; Rieckmann N
Eur J Public Health; 2012 Dec; 22(6):808-13. PubMed ID: 22199161
[TBL] [Abstract][Full Text] [Related]
32. Barriers to human papillomavirus vaccine acceptability in Israel.
Fisher WA; Laniado H; Shoval H; Hakim M; Bornstein J
Vaccine; 2013 Nov; 31 Suppl 8():I53-7. PubMed ID: 24229720
[TBL] [Abstract][Full Text] [Related]
33. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
de Kok IM; van Ballegooijen M; Habbema JD
J Natl Cancer Inst; 2009 Aug; 101(15):1083-92. PubMed ID: 19571256
[TBL] [Abstract][Full Text] [Related]
35. Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California.
Almeida CM; Tiro JA; Rodriguez MA; Diamant AL
Vaccine; 2012 Apr; 30(19):3003-8. PubMed ID: 22326776
[TBL] [Abstract][Full Text] [Related]
36. Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention.
Steens A; Wielders CC; Bogaards JA; Boshuizen HC; de Greeff SC; de Melker HE
Int J Cancer; 2013 Feb; 132(4):932-43. PubMed ID: 22689326
[TBL] [Abstract][Full Text] [Related]
37. "Who will take the blame?": understanding the reasons why Romanian mothers decline HPV vaccination for their daughters.
Craciun C; Baban A
Vaccine; 2012 Nov; 30(48):6789-93. PubMed ID: 23017603
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.
Bednarczyk RA; Birkhead GS; Morse DL; Doleyres H; McNutt LA
Vaccine; 2011 Apr; 29(17):3138-43. PubMed ID: 21376797
[TBL] [Abstract][Full Text] [Related]
40. Introduction of human papillomavirus vaccination in Nordic countries.
Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
